治疗糖尿病口服降糖药新进展(4)
[17] Gantz I， Chen M， Suryawanshi S， et al. A randomized， placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus[J/OL]. Cardiovasc Diabetol ......
您现在查看是摘要页，全文长 1694 字符。